Going Public With Ross Mandell

Join Ross’s Patreon Community for exclusive content and LIVE events
https://www.patreon.com/cw/TheRealRossMandell?utm_campaign=creatorshare_creator

What makes an entrepreneur spend $3 million on a machine to produce water? Patriox founder Teresa Reile joins Ross Mandell on Going Public to discuss the production equipment she says cost $3 million, her oxygen-rich water business, and the journey from meeting an inventor in Hungary to bringing the product to the United States.

Teresa shares her entrepreneurial background, including the 48 companies she says she and her former husband owned. The conversation explores commercial rights, product pricing, and the plans discussed at recording for manufacturing in Georgia and a wellness spa in Florida. Ross and Teresa examine how a personal experience became the motivation for a new business venture.

The interview also covers Teresa’s accounts of prison rehabilitation work in Mexico, community projects in Buffalo, and her personal health journey. Join Going Public with Ross Mandell for a conversation about entrepreneurship, product development, and building a wellness brand. Medical statements and testimonials reflect the speakers’ claims and experiences; this interview does not establish their effectiveness or provide medical advice.

About Ross Mandell:
Ross Mandell is a former Wall Street professional, entrepreneur, author, and capital formation expert. On Going Public with Ross Mandell, Ross interviews athletes, entrepreneurs, investors, doctors, creators, and high performers about success, failure, reinvention, money, health, business, and what it takes to rebuild after adversity.

This content is for informational and educational purposes only and does not constitute financial or investment advice.

🔗 Links & Resources
📌 Book A Call With Ross
https://buy.stripe.com/9B64gydlh4dJfhXecP5Vu08

📲 Follow Ross Mandell on Instagram
https://www.instagram.com/rossmandell/

📲 Follow Teresa On Instagram
https://instagram.com/prbytr?xtok=MXgwOXN1Z2EwcDY1cw%3D%3D

https://patriox.us/

⏱️ Chapters
00:00 Meet Teresa Reile, Founder of Patriox
03:44 Owning 48 Companies: Teresa’s Entrepreneurial Background
07:52 Inside Mexico’s Prisons: Rehabilitation and Second Chances
15:10 Tackling Gang Violence and Rebuilding Homes in Buffalo
21:01 What Is Patriox Oxygen Water?
22:44 Teresa’s Cancer Surgery and Personal Health Journey
26:13 Discovering Oxygen Water and Traveling to Hungary
30:39 Partnering With the Inventor Behind Patriox
35:27 Oxygen Water Research: Teresa’s Account
37:39 The $3 Million Water Machine and Exclusive Business Rights
40:19 Patriox Pricing and Plans for a Florida Wellness Spa
44:53 Teresa’s Personal Experience With Oxygen Water
49:56 Oxygen and Mitochondria: Teresa’s Perspective
51:43 Bringing Patriox Manufacturing to the United States
54:35 Ross and Teresa Discuss the Business of Healthcare
57:45 Where to Find Patriox and the Meaning Behind Its Name

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Ross’s Patreon Community for exclusive content and LIVE events
https://www.patreon.com/cw/TheRealRossMandell?utm_campaign=creatorshare_creator

Could Okta stock benefit from the AI agent boom? In this episode of Going Public with Ross Mandell, Ross explores why identity security could become increasingly important as autonomous AI agents access company data, execute tasks, and interact with sensitive systems. Learn why he’s watching OKTA stock and believes the company’s opportunity could extend far beyond passwords and single sign-on.

The discussion covers Okta’s Auth0 acquisition, workforce and customer identity, and the expanding need to secure machines and AI agents. Ross breaks down Okta’s earnings, subscription revenue, contracted business, free cash flow, and improving profitability, examining whether the company can combine financial discipline with a new market for AI security.

Ross also addresses competition from Microsoft, past security incidents, and the risks of expecting an immediate return to rapid revenue growth. Discover why he believes identity and access management could become a critical part of the AI economy—and what Okta still needs to prove. Subscribe to Going Public for more stock market analysis, cybersecurity stocks, and emerging technology investment themes.

About Ross Mandell:
Ross Mandell is a former Wall Street professional, entrepreneur, author, and capital formation expert. On Going Public with Ross Mandell, Ross interviews athletes, entrepreneurs, investors, doctors, creators, and high performers about success, failure, reinvention, money, health, business, and what it takes to rebuild after adversity.

This content is for informational and educational purposes only and does not constitute financial or investment advice.

🔗 Links & Resources
📌 Book A Call With Ross
https://buy.stripe.com/9B64gydlh4dJfhXecP5Vu08

📲 Follow Ross Mandell on Instagram
https://www.instagram.com/rossmandell/

⏱️ Chapters
00:00 Okta Stock: Who Controls AI Agents?
01:19 What Is Okta? Identity Security Explained
02:55 Okta’s Auth0 Acquisition: Workforce vs. Customer Identity
03:55 AI Agents and the Future of Identity Security
05:22 How Okta Could Secure the AI Workforce
06:26 Okta Earnings: Revenue Growth and Contracted Business
07:25 Okta’s Enterprise Customers and Switching Costs
08:05 Okta Free Cash Flow, Profitability and Growth Outlook
09:59 Okta Stock Risks: Microsoft Competition and Security Incidents
10:46 Why AI Could Multiply Demand for Identity Security
13:17 OKTA Stock Analysis: Is the AI Opportunity Priced In?
14:43 Join Ross Mandell on Patreon

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Ross’s Patreon Community for exclusive content and LIVE events
https://www.patreon.com/cw/TheRealRossMandell?utm_campaign=creatorshare_creator
What does NVIDIA’s $235 billion stock buyback authorization reveal about its future? In this episode of Going Public with Ross Mandell, Ross breaks down NVIDIA stock, Jensen Huang’s strategy, and why he views the expanded share repurchase program as a powerful bullish signal. Explore how the company’s AI business could support both continued growth and substantial returns of capital to shareholders.
Learn how stock buybacks can affect earnings per share, share count, and shareholder value. Ross examines NVIDIA’s free cash flow, stock-based compensation, valuation, and the AI infrastructure spending driving demand for its chips. He also explains why earnings growth matters when evaluating NVDA stock and compares NVIDIA’s approach with Apple’s buyback history.
From NVIDIA’s beginnings at Denny’s to its expansion into robotics, networking, and automotive technology, this episode explores the company’s evolution and the challenges ahead. Ross addresses concerns about AI spending and semiconductor boom-and-bust cycles while explaining why NVIDIA remains his biggest stock position. Subscribe to Going Public for more stock market analysis, AI stocks, and investing insights with Ross Mandell.
About Ross Mandell:
Ross Mandell is a former Wall Street professional, entrepreneur, author, and capital formation expert. On Going Public with Ross Mandell, Ross interviews athletes, entrepreneurs, investors, doctors, creators, and high performers about success, failure, reinvention, money, health, business, and what it takes to rebuild after adversity.
This content is for informational and educational purposes only and does not constitute financial or investment advice.
🔗 Links & Resources
📌 Book A Call With Ross
https://buy.stripe.com/9B64gydlh4dJfhXecP5Vu08
📲 Follow Ross Mandell on Instagram
https://www.instagram.com/rossmandell/
⏱️ Chapters
00:00 NVIDIA Stock: The $235 Billion Buyback Story
01:05 NVIDIA’s Origins: Jensen Huang and the AI Revolution
02:16 NVIDIA’s $235 Billion Stock Buyback Plan
02:54 How Stock Buybacks Affect Earnings per Share
04:23 NVIDIA Free Cash Flow and AI Infrastructure Demand
05:25 NVIDIA Buyback Math: Share Count and Stock Dilution
06:17 What NVIDIA’s Buyback Signals About Its Future
07:02 NVIDIA Stock Valuation: Earnings Growth and P/E Ratio
07:54 NVIDIA vs. Apple: Buybacks and Shareholder Returns
08:56 NVIDIA Stock Risks: AI Spending and Chip Cycles
09:55 Why Ross Mandell Is Bullish on NVIDIA Stock

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Ross’s Patreon Community for exclusive content and LIVE events
https://www.patreon.com/cw/TheRealRossMandell?utm_campaign=creatorshare_creator
Is Eli Lilly stock still in the early stages of the weight-loss boom? In this episode of Going Public with Ross Mandell, Ross breaks down his bullish outlook on LLY stock and explains why Mounjaro and Zepbound could be just the beginning. Explore how diabetes treatments, obesity drugs, and the growing GLP-1 market fit into his investment thesis.
The discussion covers oral weight-loss treatments such as orforglipron, retatrutide’s clinical development, and Lilly’s plans to expand manufacturing and reach more patients worldwide. Ross examines the company’s earnings, revenue growth, and drug pipeline, explaining why he sees an opportunity extending beyond today’s blockbuster injections.
Ross also addresses Eli Lilly’s stock pullback, valuation, competition from Novo Nordisk and other drugmakers, and the execution risks investors should watch. Learn which developments he’s tracking—from clinical trial results and international expansion to production capacity and financial guidance—and why a strong business still needs to justify its stock price. Subscribe to Going Public for more stock market analysis, healthcare stocks, and emerging investment themes.
About Ross Mandell:
Ross Mandell is a former Wall Street professional, entrepreneur, author, and capital formation expert. On Going Public with Ross Mandell, Ross interviews athletes, entrepreneurs, investors, doctors, creators, and high performers about success, failure, reinvention, money, health, business, and what it takes to rebuild after adversity.
This content is for informational and educational purposes only and does not constitute financial or investment advice.
🔗 Links & Resources
📌 Book A Call With Ross
https://buy.stripe.com/9B64gydlh4dJfhXecP5Vu08
📲 Follow Ross Mandell on Instagram
https://www.instagram.com/rossmandell/
⏱️ Chapters
00:00 Eli Lilly Stock: The Next Phase of the Weight-Loss Boom
01:13 Eli Lilly’s History: From Insulin to Obesity Drugs
02:16 Mounjaro and Zepbound: Eli Lilly’s Revenue Growth
03:21 Orforglipron: The Oral Weight-Loss Pill Opportunity
05:20 Eli Lilly’s Manufacturing Expansion
06:12 Retatrutide Clinical Trials: The Triple-Action Obesity Drug
07:43 GLP-1 Research: New Data and Combination Treatments
08:22 Eli Lilly’s Drug Pipeline Beyond Weight Loss
09:07 LLY Stock Pullback and Revenue Guidance
10:16 Eli Lilly Stock Valuation and Novo Nordisk Competition
11:30 Why Ross Mandell Is Bullish on Eli Lilly Stock
13:18 Eli Lilly Stock: Key Catalysts and Risks to Watch
14:07 Why the Weight-Loss Boom Could Be Just Beginning

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Ross’s Patreon Community for exclusive content and LIVE events
https://www.patreon.com/cw/TheRealRossMandell?utm_campaign=creatorshare_creator
Could Ouster stock benefit from the rise of physical AI? In this episode of Going Public with Ross Mandell, Ross explains why he owns OUST and how digital lidar gives robots, drones, and autonomous machines the ability to “see.” Explore his investment thesis as artificial intelligence expands into factories, farms, warehouses, and smart infrastructure.
The conversation covers Ouster’s Velodyne merger, revenue growth, Rev8 native color lidar, and support for the NVIDIA Jetson ecosystem. Ross examines autonomous agriculture through John Deere’s GUSS subsidiary, drone inspection, and industrial automation, explaining why he believes Ouster’s opportunity extends well beyond self-driving cars.
Ross also breaks down the OUST stock pullback, capital raises, shareholder dilution, competition, and the path toward profitability. Learn which customer deployments, software opportunities, margins, and earnings trends he’s watching—and why he remains bullish while acknowledging the risks. Subscribe to Going Public for more stock market analysis and insights into AI stocks, robotics, and emerging technology.
About Ross Mandell:
Ross Mandell is a former Wall Street professional, entrepreneur, author, and capital formation expert. On Going Public with Ross Mandell, Ross interviews athletes, entrepreneurs, investors, doctors, creators, and high performers about success, failure, reinvention, money, health, business, and what it takes to rebuild after adversity.
This content is for informational and educational purposes only and does not constitute financial or investment advice.
🔗 Links & Resources
📌 Book A Call With Ross
https://buy.stripe.com/9B64gydlh4dJfhXecP5Vu08
📲 Follow Ross Mandell on Instagram
https://www.instagram.com/rossmandell/
⏱️ Chapters
00:00 Ouster Stock: The Eyes of Physical AI
01:11 What Is Ouster? Lidar Technology Explained
04:18 Ouster’s Velodyne Merger Explained
06:25 Physical AI: Robotics and Industrial Automation
07:48 Ouster and John Deere’s GUSS: Autonomous Farming
08:27 Ouster Lidar for Drone Mapping and Inspection
09:26 Ouster Rev8: Native Color Lidar Explained
10:11 Ouster and NVIDIA Jetson: Robotics and Edge AI
11:09 OUST Stock Pullback: Price vs. Business Performance
13:01 Ouster Stock Risks and the Path to Profitability

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.